PT428 Rick Doblin, Ph.D. The Promise of MAPS' Phase III Data, Psychedelics and Adolescents, and the Need for Honest Drug Education
In this episode, recorded on the eve of MAPS\u2019 Psychedelic Science 2023, Kyle interviews MAPS\u2019 Founder and President, Rick Doblin, Ph.D.
He begins with an overview of the fast-approaching (and largest ever) psychedelics conference, emphasizing its significant growth, many features, and bipartisan opening ceremony, then discusses MAPS\u2019 soon-to-be-released confirmatory Phase III data on MDMA-assisted therapy for PTSD, which should set the stage for legal MDMA and the increasing need for trained psychedelic therapists.\xa0
As the FDA is requiring studies on adolescents, he discusses this sensitive issue and questions why it\u2019s so controversial, since teenage years are often closer to both trauma and a more malleable brain, Indigenous traditions certainly didn\u2019t have age limits, and honest drug education \u2013 something that is absolutely necessary to fight the backlash against this quickly growing field \u2013 teaches us that it\u2019s not the substance; it\u2019s our relationship to it. Could not having these rites of passage be hurting us?
He also discusses the natural vs. synthetic conflict; breathwork; whether or not cannabis is truly damaging to young minds; Federal rescheduling vs. state rescheduling; why it\u2019s controversial to give therapists MDMA in training; Gul Dolen\u2019s work with reopening critical periods; psychedelics in couples therapy; and much more.
Click here to head to the show notes page.